Amanda Roberts

Dr. Amanda Roberts

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2002
Verified
Journal Article
Closed access
GVGlenn R Valdez
Glenn R Valdez
ARAmanda Roberts
Amanda Roberts
KCKaren Chan
Karen Chan
HDHeather Davis
Heather Davis
MBMolly Brennan
Molly Brennan
GKGeorge F Koob
George F Koob
Animal models of alcohol dependence suggest that long-term alterations in brain corticotropin-releasing factor (CRF) systems, key mediators of the behavioral stress response, may be involved in the development and reinstatement of dependence on drugs of abuse. The objective of the present study was to investigate the role of CRF in the regulation of ethanol self-administration and to examine the behavioral stress response during acute withdrawal and protracted abstinence. Male Wistar rats were made dependent on ethanol via chronic exposure to ethanol vapor. Ethanol self-administration and exploratory behavior in the elevated plus maze were measured at 2 hr and 3 to 5 weeks after exposure. The role of CRF in ethanol self-administration was examined via central injection of the CRF receptor antagonist D-Phe-CRF(12-41). Rats showed increased responding for ethanol 2 hr and 3 to 5 weeks after chronic ethanol exposure, which was attenuated by central injection of D-Phe-CRF(12-41). In addition, rats displayed a decrease in open-arm exploration in the elevated plus maze when tested 2 hr and 4 weeks after exposure. These results indicate that chronic ethanol exposure leads to increased ethanol self-administration and decreased open-arm exploration in the elevated plus maze during acute withdrawal and protracted abstinence. Attenuation of ethanol self-administration via central injection of D-Phe-CRF(12-41) implicates CRF as an underlying mechanism regulating long-term motivational effects associated with alcohol dependence.

1 June 2000 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
ARAmanda Roberts
Amanda Roberts
JMJeffrey S. McDonald
Jeffrey S. McDonald
CHCharles J. Heyser
Charles J. Heyser
BKBrigitte L. Kieffer
Brigitte L. Kieffer
HMHans W.D. Matthes
Hans W.D. Matthes
LGLisa H. Gold
Lisa H. Gold

1 May 2014 in Alcohol
Verified
Journal Article
Closed access
LVLeandro F. Vendruscolo
Leandro F. Vendruscolo
ARAmanda Roberts
Amanda Roberts

1 April 2007 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
KCKathleen Chu
Kathleen Chu
GKGeorge F. Koob
George F. Koob
MCMaury Cole
Maury Cole
EZEric P. Zorrilla
Eric P. Zorrilla
ARAmanda Roberts
Amanda Roberts

10 March 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
AMAna M. Moreno
Ana M. Moreno
FAFernando Alemán
Fernando Alemán
GCGlaucilene F. Catroli
Glaucilene F. Catroli
MHMatthew Hunt
Matthew Hunt
MHMichael Hu
Michael Hu
PMPrashant Mali
Prashant Mali
In situ genome targeting of Na V 1.7 via CRISPRs and zinc fingers enables genomically scarless, durable, and nonaddictive management of pain.

1 May 2010 in Behavioural Brain Research
Verified
Journal Article
Closed access
GSGor Sarkisyan
Gor Sarkisyan
ARAmanda Roberts
Amanda Roberts
PHPeter B. Hedlund
Peter B. Hedlund